Home/Filings/4/0001651308-25-000089
4//SEC Filing

BRANDICOURT OLIVIER 4

Accession 0001651308-25-000089

CIK 0001651308other

Filed

May 21, 8:00 PM ET

Accepted

May 22, 7:46 PM ET

Size

8.1 KB

Accession

0001651308-25-000089

Insider Transaction Report

Form 4
Period: 2025-05-21
Transactions
  • Award

    Ordinary Shares

    2025-05-21+10,98527,326 total
  • Award

    Share Option (Right to Buy)

    2025-05-21+22,75022,750 total
    Exercise: $18.19Exp: 2035-05-20Ordinary Shares (22,750 underlying)
Footnotes (3)
  • [F1]Represents securities underlying restricted share units. The restricted share units shall become fully vested on the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the director resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. The restricted share units were granted under the Company's Independent Director Compensation Policy, as amended.
  • [F2]The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares.
  • [F3]The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. The option was granted under the Company's Independent Director Compensation Policy, as amended.

Issuer

BeiGene, Ltd.

CIK 0001651308

Entity typeother

Related Parties

1
  • filerCIK 0001508518

Filing Metadata

Form type
4
Filed
May 21, 8:00 PM ET
Accepted
May 22, 7:46 PM ET
Size
8.1 KB